Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors

IMPORTANCE: New dosing options for immune checkpoint inhibitors have recently been approved by the US Food and Drug Administration (FDA), including fixed dosing with extended intervals. Although the dose intensity appears the same, there is expected to be some waste with extended-interval dosing, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Daniel A., Ginsberg, Gary M., Hofnung-Gabbay, Dorit, De Abreu Lourenco, Richard, Loong, Herbert H., Goh, Boon Cher, Chan, Kelvin K. W., Di Maio, Massimo, Perrone, Francesco, Hall, Peter S., Zer, Alona, Rosenbaum, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951041/
https://www.ncbi.nlm.nih.gov/pubmed/36821111
http://dx.doi.org/10.1001/jamanetworkopen.2023.0490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951041/
https://www.ncbi.nlm.nih.gov/pubmed/36821111
http://dx.doi.org/10.1001/jamanetworkopen.2023.0490

Ejemplares similares